COVID-19 outcomes and the human genome

Genet Med. 2020 Jul;22(7):1175-1177. doi: 10.1038/s41436-020-0832-3. Epub 2020 May 12.

Authors

Michael F Murray¹, Eimear E Kenny², Marylyn D Ritchie³, Daniel J Rader³, Allen E Bale⁴, Monica A Giovanni⁴, Noura S Abul-Husn²

Affiliations

¹ Department of Genetics, Yale School of Medicine, New Haven, CT, USA. michael.murray@yale.edu.
² Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
³ Department of Genetics, University of Pennsylvania, Philadelphia, PA, USA.
⁴ Department of Genetics, Yale School of Medicine, New Haven, CT, USA.

No abstract available

MeSH terms

Betacoronavirus / pathogenicity*
COVID-19
Coronavirus Infections / epidemiology
Coronavirus Infections / genetics*
Coronavirus Infections / mortality
Coronavirus Infections / virology
Disease Resistance / genetics*
Genetic Predisposition to Disease*
Genome, Human / genetics*
Host-Pathogen Interactions / genetics
Humans
Pandemics
Pneumonia, Viral / epidemiology
Pneumonia, Viral / genetics*
Pneumonia, Viral / mortality
Pneumonia, Viral / virology
SARS-CoV-2